$7.91
-0.06-0.75%
Last update: Nov 5, 9:31 AM
Electra Therapeutics Inc
ETRANASDAQ
The average analyst price target for Electra Therapeutics is $33.50, 323.5% above the current price. Of 6 analysts, 6 rate it Buy. Targets range from $30 to $36. The latest change came on Oct 23, 2026, when HC Wainwright & Co. initiated coverage of Electra Therapeutics with a Buy rating and a $30 price target.
Price Target Range — 1 Quarters
Analyst Consensus — 6 Analysts
Rating Trend — Last 9 Months
